封面
市場調查報告書
商品編碼
1269394

心房顫動手術設備市場(手術:心導管電氣燒灼術,手術切除)-全球產業分析,規模,佔有率,成長,趨勢,預測,2022-2031年

Atrial Fibrillation Surgery Devices Market (Procedure: Catheter Ablation and Surgical Ablation) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

出版日期: | 出版商: Transparency Market Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

心房顫動手術設備市場- 調查範圍:

本報告提供了2017年至2031年全球房顫手術器械市場收入,其中2022年為基準年,2031年為預測年。它還列出了2022年至2031年全球心房顫動手術器械市場的複合年增長率。

本報告是廣泛研究的結果。在初級研究中,分析師對關鍵思想領袖、行業領袖和輿論製造者進行採訪,並開展大部分研究工作。二次研究查閱了主要參與者的產品文獻、年度報告、新聞稿、相關文件等,以了解心房顫動手術器械市場。

該報告深入研究了全球心房顫動手術器械市場的競爭格局。已經確定了全球心房顫動手術設備市場的主要參與者,並對這些公司中的每家公司進行了各種屬性的分析。公司簡介、財務狀況、最新發展和 SWOT 是本報告中介紹的全球心房顫動手術設備市場參與者的屬性。

目錄

第1章 序文

  • 市場定義和範圍
  • 市場區隔
  • 主要的調查目的
  • 調查亮點

第2章 前提條件與調查手法

第3章 摘要整理:全球市場

第4章 市場概要

  • 簡介
    • 過程定義
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球市場的分析與預測,2017-2031年
    • 波特的五力分析

第5章 主要洞察

  • 世界各國的疾病盛行率及發病率
  • 技術的進步
  • 心房顫動概要
  • COVID-19大流行病對產業帶來的影響(價值鏈,短期·中期·長期性的影響)

第6章 全球市場分析·預測:手藝

  • 簡介和定義
  • 主要的知識和見識/發展
  • 市場價值預測:手藝,2017年~2031年
    • 心導管電氣燒灼術
      • 射頻燒灼術療法
      • 冷凍消融
    • 手術切除
      • 會聚切除
      • maize切除
  • 市場魅力分析:手術

第7章 全球市場分析·預測:各終端用戶

  • 簡介&定義
  • 主要調查結果/發展情形
  • 市場規模預測:各終端用戶,2017年~2031年
    • 醫院
    • 專門醫院
    • 門診病人手術中心
    • 其他
  • 市場魅力分析:各終端用戶

第8章 全球市場分析·預測:各地區

  • 主要調查結果
  • 市場價值預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲地區
  • 市場魅力分析:各地區

第9章 北美市場分析·預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:手術,2017-2031年
    • 心導管電氣燒灼術
      • 射頻切除
      • 冷凍消融
    • 手術切除
      • 會聚切除
      • maize切除
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國,2017-2031年
    • 美國
    • 加拿大
  • 市場魅力分析
    • 手術
    • 各終端用戶
    • 各國

第10章 歐洲市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:手術,2017-2031年
    • 心導管電氣燒灼術
      • 射頻切除
      • 冷凍消融
    • 手術切除
      • 會聚切除
      • maize切除
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國/子地區,2017-2031年
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲
  • 市場魅力分析
    • 次序
    • 各終端用戶
    • 各國/子地區

第11章 亞太地區的市場分析與預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:手術,2017-2031年
    • 心導管電氣燒灼術
      • 射頻切除
      • 冷凍消融
    • 手術切除
      • 會聚切除
      • maize切除
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國/子地區,2017-2031年
    • 中國
    • 日本
    • 印度
    • 澳洲·紐西蘭
    • 其他亞太地區
  • 市場魅力分析
    • 次序
    • 各終端用戶
    • 各國/子地區

第12章 南美的市場分析·預測

  • 簡介
    • 主要的調查結果
  • 市場價值預測:手術,2017-2031年
    • 心導管電氣燒灼術
      • 射頻切除
      • 冷凍消融
    • 手術切除
      • 會聚切除
      • maize切除
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國/子地區,2017-2031年
    • 巴西
    • 墨西哥
    • 其他南美國家地區
  • 市場魅力分析
    • 手術
    • 各終端用戶
    • 各國/子地區

第13章 中東·非洲市場分析·預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:手術,2017-2031年
    • 心導管電氣燒灼術
      • 射頻燒灼術療法
      • 冷凍消融
    • 手術切除
      • 會聚切除
      • maize切除
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門醫院
    • 門診病人手術中心
    • 其他
  • 市場價值預測:各國/子地區,2017-2031年
    • GCC各國
    • 南非
    • 其他中東·非洲
  • 市場魅力分析
    • 手術
    • 各終端用戶
    • 各國/子地區

第14章 競爭情形

  • 市場企業-競爭矩陣(各層級,不同企業規模)
  • 市場佔有率分析:各企業(2022年)
  • 企業簡介
    • AtriCure, Inc.
    • CardioFocus, Inc.
    • Abbott Laboratories
    • Biosense Webster, Inc.
    • Medtronic plc
    • Boston Scientific Corporation
    • Osypka AG
    • Kardium, Inc.
    • Acutus Medical, Inc.
    • Koninklijke Philips N.V.
Product Code: TMRGL85475

Atrial Fibrillation Surgery Devices Market - Scope of Report:

TMR's report on the global atrial fibrillation surgery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global atrial fibrillation surgery devices market for the period 2017-2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global atrial fibrillation surgery devices market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the atrial fibrillation surgery devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global atrial fibrillation surgery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global atrial fibrillation surgery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global atrial fibrillation surgery devices market.

The report delves into the competitive landscape of the global atrial fibrillation surgery devices market. Key players operating in the global atrial fibrillation surgery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global atrial fibrillation surgery devices market profiled in this report.

Key Questions Answered in Global Atrial Fibrillation Surgery Devices Market Report:

  • What is the sales/revenue generated by atrial fibrillation surgery devices across all regions during the forecast period?
  • What are the opportunities in the global atrial fibrillation surgery devices market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Atrial Fibrillation Surgery Devices Market - Research Objectives and Research Approach:

The comprehensive report on the global atrial fibrillation surgery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global atrial fibrillation surgery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global atrial fibrillation surgery devices market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Atrial Fibrillation Surgery Devices Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Procedure Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, 2017-2031
    • 4.4.1. Porter's Five Forces Analysis

5. Key Insights

  • 5.1. Disease Prevalence & Incidence Rate Globally With Key Countries
  • 5.2. Technological Advancements
  • 5.3. Overview of Atrial Fibrillation
  • 5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)

6. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Procedure

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Procedure, 2017-2031
    • 6.3.1. Catheter Ablation
      • 6.3.1.1. Radiofrequency Ablation
      • 6.3.1.2. Cryoablation
    • 6.3.2. Surgical Ablation
      • 6.3.2.1. Convergent Ablation
      • 6.3.2.2. Maze Ablation
  • 6.4. Market Attractiveness Analysis, by Procedure

7. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by End-user

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by End-user, 2017-2031
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Centers
    • 7.3.3. Ambulatory Surgical Centers
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by End-user

8. Global Atrial Fibrillation Surgery Devices Market Analysis and Forecast, by Region

  • 8.1. Key Findings
  • 8.2. Market Value Forecast, by Region
    • 8.2.1. North America
    • 8.2.2. Europe
    • 8.2.3. Asia Pacific
    • 8.2.4. Latin America
    • 8.2.5. Middle East & Africa
  • 8.3. Market Attractiveness Analysis, by Region

9. North America Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
  • 9.2. Market Value Forecast, by Procedure, 2017-2031
    • 9.2.1. Catheter Ablation
      • 9.2.1.1. Radiofrequency Ablation
      • 9.2.1.2. Cryoablation
    • 9.2.2. Surgical Ablation
      • 9.2.2.1. Convergent Ablation
      • 9.2.2.2. Maze Ablation
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Centers
    • 9.3.3. Ambulatory Surgical Centers
    • 9.3.4. Others
  • 9.4. Market Value Forecast, by Country, 2017-2031
    • 9.4.1. U.S.
    • 9.4.2. Canada
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Procedure
    • 9.5.2. By End-user
    • 9.5.3. By Country

10. Europe Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Procedure, 2017-2031
    • 10.2.1. Catheter Ablation
      • 10.2.1.1. Radiofrequency Ablation
      • 10.2.1.2. Cryoablation
    • 10.2.2. Surgical Ablation
      • 10.2.2.1. Convergent Ablation
      • 10.2.2.2. Maze Ablation
  • 10.3. Market Value Forecast, by End-user, 2017-2031
    • 10.3.1. Hospitals
    • 10.3.2. Specialty Centers
    • 10.3.3. Ambulatory Surgical Centers
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 10.4.1. Germany
    • 10.4.2. U.K.
    • 10.4.3. France
    • 10.4.4. Italy
    • 10.4.5. Spain
    • 10.4.6. Rest of Europe
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Procedure
    • 10.5.2. By End-user
    • 10.5.3. By Country/Sub-region

11. Asia Pacific Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Procedure, 2017-2031
    • 11.2.1. Catheter Ablation
      • 11.2.1.1. Radiofrequency Ablation
      • 11.2.1.2. Cryoablation
    • 11.2.2. Surgical Ablation
      • 11.2.2.1. Convergent Ablation
      • 11.2.2.2. Maze Ablation
  • 11.3. Market Value Forecast, by End-user, 2017-2031
    • 11.3.1. Hospitals
    • 11.3.2. Specialty Centers
    • 11.3.3. Ambulatory Surgical Centers
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.4.1. China
    • 11.4.2. Japan
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. Rest of Asia Pacific
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Procedure
    • 11.5.2. By End-user
    • 11.5.3. By Country/Sub-region

12. Latin America Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Procedure, 2017-2031
    • 12.2.1. Catheter Ablation
      • 12.2.1.1. Radiofrequency Ablation
      • 12.2.1.2. Cryoablation
    • 12.2.2. Surgical Ablation
      • 12.2.2.1. Convergent Ablation
      • 12.2.2.2. Maze Ablation
  • 12.3. Market Value Forecast, by End-user, 2017-2031
    • 12.3.1. Hospitals
    • 12.3.2. Specialty Centers
    • 12.3.3. Ambulatory Surgical Centers
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.4.1. Brazil
    • 12.4.2. Mexico
    • 12.4.3. Rest of Latin America
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Procedure
    • 12.5.2. By End-user
    • 12.5.3. By Country/Sub-region

13. Middle East & Africa Atrial Fibrillation Surgery Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Procedure, 2017-2031
    • 13.2.1. Catheter Ablation
      • 13.2.1.1. Radiofrequency Ablation
      • 13.2.1.2. Cryoablation
    • 13.2.2. Surgical Ablation
      • 13.2.2.1. Convergent Ablation
      • 13.2.2.2. Maze Ablation
  • 13.3. Market Value Forecast, by End-user, 2017-2031
    • 13.3.1. Hospitals
    • 13.3.2. Specialty Centers
    • 13.3.3. Ambulatory Surgical Centers
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.4.1. GCC Countries
    • 13.4.2. South Africa
    • 13.4.3. Rest of Middle East & Africa
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Procedure
    • 13.5.2. By End-user
    • 13.5.3. By Country/Sub-region

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (by tier and size of companies)
  • 14.2. Market Share Analysis, by Company (2022)
  • 14.3. Company Profiles
    • 14.3.1. AtriCure, Inc.
      • 14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. Financial Overview
      • 14.3.1.4. SWOT Analysis
      • 14.3.1.5. Strategic Overview
    • 14.3.2. CardioFocus, Inc.
      • 14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. Financial Overview
      • 14.3.2.4. SWOT Analysis
      • 14.3.2.5. Strategic Overview
    • 14.3.3. Abbott Laboratories
      • 14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. Financial Overview
      • 14.3.3.4. SWOT Analysis
      • 14.3.3.5. Strategic Overview
    • 14.3.4. Biosense Webster, Inc.
      • 14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. Financial Overview
      • 14.3.4.4. SWOT Analysis
      • 14.3.4.5. Strategic Overview
    • 14.3.5. Medtronic plc
      • 14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. Financial Overview
      • 14.3.5.4. SWOT Analysis
    • 14.3.6. Boston Scientific Corporation
      • 14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. Financial Overview
      • 14.3.6.4. SWOT Analysis
    • 14.3.7. Osypka AG
      • 14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. Financial Overview
      • 14.3.7.4. SWOT Analysis
    • 14.3.8. Kardium, Inc.
      • 14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. Financial Overview
      • 14.3.8.4. SWOT Analysis
    • 14.3.9. Acutus Medical, Inc.
      • 14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. Financial Overview
      • 14.3.9.4. SWOT Analysis
    • 14.3.10. Koninklijke Philips N.V.
      • 14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. Financial Overview
      • 14.3.10.4. SWOT Analysis
      • 14.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 02: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 03: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 04: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 05: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 06: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 08: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 09: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 11: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 12: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 14: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Procedure, 2017-2031
  • Table 17: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 18: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 03: Global Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 04: Global Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 05: Global Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 06: Global Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Region, 2022 and 2031
  • Figure 07: Global Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 08: North America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 09: North America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 10: North America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 11: North America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 12: North America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 13: North America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 14: North America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 15: Europe Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 16: Europe Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 17: Europe Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 18: Europe Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 19: Europe Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 20: Europe Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 21: Europe Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 22: Asia Pacific Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: Asia Pacific Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 24: Asia Pacific Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 25: Asia Pacific Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 26: Asia Pacific Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 27: Asia Pacific Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 28: Asia Pacific Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 29: Latin America Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 30: Latin America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 31: Latin America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 32: Latin America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 33: Latin America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 34: Latin America Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 35: Latin America Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 36: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 37: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Procedure, 2022 and 2031
  • Figure 38: Middle East & Africa Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Procedure, 2023-2031
  • Figure 39: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value Share Analysis, by End-user, 2022 and 2031
  • Figure 40: Middle East & Africa Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 41: Middle East & Africa Atrial Fibrillation Surgery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
  • Figure 42: Middle East & Africa Atrial Fibrillation Surgery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 43: Global Atrial Fibrillation Surgery Devices Market Share Analysis, by Company, 2022